U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 19:21:44 UTC 2023
Edited
by admin
on Sat Dec 16 19:21:44 UTC 2023
Protein Type ION CHANNEL
Protein Sub Type GABA RECEPTOR
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
RU3465V8V1
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GABAA RECEPTOR
Common Name English
GABAAR
Common Name English
GAMMA-AMINOBUTYRIC ACID A RECEPTOR
Common Name English
.GAMMA.-AMINOBUTYRIC ACID A RECEPTOR
Common Name English
GABA A RECEPTOR
Common Name English
Code System Code Type Description
FDA UNII
RU3465V8V1
Created by admin on Sat Dec 16 19:21:49 UTC 2023 , Edited by admin on Sat Dec 16 19:21:49 UTC 2023
PRIMARY
Related Record Type Details
INHIBITOR -> TARGET
INHIBITOR -> TARGET
OFF-TARGET ACTIVITY: INHIBITING LIGAND BINDING TO THE AGBAA CHLORIDE ION CHANNEL
INHIBITOR -> TARGET
OFF-TARGET ACTIVITY: INHIBITING LIGAND BINDING TO GABAA CHLORIDE ION CHANNEL
AGONIST -> TARGET
Etizolam acts as a full agonist at the benzodiazepine/GABAa receptor to produce its range of therapeutic and adverse effects.
AGONIST -> TARGET
SL651498 is a subtype-selective GABAA agonist, which acts as a full agonist at α2 and α3 subtypes, and as a partial agonist at α1 and α5 (although its action at α5 subtypes is much weaker than at the others).
POSITIVE ALLOSTERIC MODULATOR (PAM)->TARGET
POSITIVE ALLOSTERIC MODULATOR (PAM)->TARGET
INHIBITOR->OFF-TARGET
OFF-TARGET ACTIVITY: INHIBITING LIGAND BINDING TO THE GABAA CHLORIDE ION CHANNEL
AGONIST -> TARGET
INHIBITOR -> TARGET
Has been used as an antidote in the treatment of benzodiazepine and Z-drug overdoses.[
MODULATOR->TARGET
ALLOSTERIC ACTIVATOR
PARTIAL AGONIST->TARGET
Its affinity and efficacy profile were comparable to pagoclone with the exception that efficacy at the α1 subtype was considerably greater for 5′-hydroxy pagoclone compared with the parent.
PARTIAL AGONIST->TARGET
MODULATOR->TARGET
ACTIVATOR -> TARGET
ALLOSTERIC ACTIVATOR
AGONIST -> TARGET
INHIBITOR -> TARGET
AGONIST -> TARGET
MODULATOR->TARGET
INVERSE AGONIST->TARGET
Non selective GABAA inverse agonist. Therapeutic potential is limited by severe side effects (anxiogenic, convulsant, and proconvulsant).
ALLOSTERIC
NEGATIVE ALLOSTERIC MODULATOR (NAM)->TARGET
POSITIVE ALLOSTERIC MODULATOR (PAM)->TARGET
AGONIST -> TARGET
POSITIVE ALLOSTERIC MODULATOR (PAM)->TARGET
ACTIVATOR -> TARGET
MODULATOR
ALLOSTERIC
PARTIAL AGONIST->TARGET
AGONIST -> TARGET
MODULATOR->TARGET
PARTIAL AGONIST->TARGET
PARTIAL AGONIST->TARGET
POSITIVE ALLOSTERIC MODULATOR (PAM)->TARGET
POSITIVE ALLOSTERIC MODULATOR (PAM)->TARGET
POSITIVE ALLOSTERIC MODULATOR (PAM)->TARGET
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL